Indeed, study [102] reports a number of protective effects caused by the loss of α4*-nAChRs on the neuropathological alterations that develop over time in Tg2576 (APPswe) mice, a widely studied mouse model of AD that expresses a human APP transgene carrying the amyloidogenic Swedish mutation. This evidence concerns the gene APP and Alzheimer disease.